Skip to content
healthcare.dev

Cyclobenzaprine Hydrochloride

NDC 43063-494, Cyclobenzaprine Hydrochloride, tablet, film coated, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-494
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078048
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-494 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
43063-494-0143063049401100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-01)
43063-494-104306304941010 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-10)
43063-494-144306304941414 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-14)
43063-494-154306304941515 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-15)
43063-494-204306304942020 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-20)
43063-494-214306304942121 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-21)
43063-494-304306304943030 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-30)
43063-494-604306304946060 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-60)
43063-494-8243063049482500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-82)
43063-494-904306304949090 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-90)
43063-494-95430630494951000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-494-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e505c31b-4618-4e4f-8da6-92030464004f

Use it

Look up 43063-494 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-494 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-494. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.